McLauchlan L, Lancaster K, Kearnes M, Mellor R, Ritter A. "It's professional but it's personal": participation, personal connection, and sustained disagreement in drug policy reform. Int J Drug Policy. 2022 Dec;110:103903. doi: 10.1016/j.drugpo.2022.103903
McKinnon CJ, Hatch EE, Orta OR, Rothman KJ, Eisenberg ML, Wefes-Potter J, Wise LA. The association between work hours, shift work, and job latitude with fecundability: a preconception cohort study. J Occup Health Psychol. 2022 Apr;27(2):258-65. doi: 10.1037/ocp0000279
Arnaud F, Spreadborough P, Mehalick M, Goforth C. Emulsion effect on the measurement of standard laboratory blood products. Clin Lab. 2020 Nov 1;66(11). doi: 10.7754/Clin.Lab.2020.191232. doi: 10.7754/Clin.Lab.2020.191232
Gourdet C, Giombi KC, Kosa K, Wiley J, Cates S. How four U.S. states are regulating recreational marijuana edibles. Int J Drug Policy. 2017 May;43:83-90. doi: 10.1016/j.drugpo.2017.01.018.
Kosa KM, Giombi KC, Rains CB, Cates SC. Consumer use and understanding of labelling information on edible marijuana products sold for recreational use in the states of Colorado and Washington. Int J Drug Policy. 2017 May;43:57-66. doi: 10.1016/j.drugpo.2017.01.006
Feltner D, Hill C, Lenderking W, Williams VS, Morlock R. Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial. J Psychiatr Res. 2009 Oct;43(15):1224-30.
Morlock RJ, Williams VS, Cappelleri JC, Harness J, Fehnel SE, Endicott J, Feltner D. Development and evaluation of the Daily Assessment of Symptoms – Anxiety (DAS-A) Scale to evaluate onset of symptom relief in patients with generalized anxiety disorder. J Psychiatr Res. 2008 Oct;42(12):1024-36.